Compare equities side by side
Stocks breaking to new annual highs
S&P 500 oversold value screener
Relative strength momentum leaders
Upcoming earnings dates & reports
Filter and sort all 500 stocks
Today's biggest gainers and losers
Visual sector performance
Integer Holdings Corporation specializes in the design and manufacturing of medical devices and components, particularly in the cardiac, neuromodulation, and vascular markets. With a strong presence in North America and Europe, the company leverages its advanced engineering capabilities and extensive manufacturing expertise to maintain a competitive edge in the rapidly evolving healthcare sector.
Integer generates revenue primarily through the sale of medical devices and components to OEMs (Original Equipment Manufacturers). The company benefits from strong pricing power due to its specialized manufacturing capabilities and established relationships with major healthcare providers, allowing it to command premium pricing in niche markets.
Regulatory approvals for new medical devices
Trends in healthcare spending and reimbursement rates
Market share changes among key competitors
Technological advancements in medical device manufacturing
Regulatory changes impacting device approvals and market access
Technological disruption from emerging medical technologies
Intensifying competition from both established players and new entrants in the medical device space
Potential for pricing pressure from larger competitors
Moderate debt levels may limit financial flexibility
Potential pension obligations impacting cash flow
moderate - Integer's performance is somewhat tied to healthcare spending, which can be influenced by economic cycles and consumer confidence.
Interest rates can affect Integer's cost of capital for financing R&D and expansion. Higher rates may compress margins due to increased borrowing costs, impacting valuation multiples.
minimal - Integer's operations are not heavily reliant on credit markets, but access to financing for growth initiatives is important.
growth - Investors looking for exposure to the healthcare sector with potential for innovation-driven revenue growth.
moderate - Historical volatility has been in line with industry peers, reflecting both growth potential and market risks.